Effect of endogenous insulin release on fetal alanine concentration and uptake

Anthony F Philipps, Joseph W. Dubin, John R. Raye

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Insulin secretion in the fetus may be important in the modulation of selected fetal amino acid concentration and uptakes. To test this hypothesis we observed the changes in fetal alanine concentrations and uptake after tolbutamide-induced insulin release in the fetal lamb. The basal umbilical venous-arterial alanine difference was 29.1 ± 4.2 μmoles/L. Fetal alanine uptake was 5.1 ± 0.6 μmoles/kg/min. After tolbutamide infusion fetal insulin concentration rose fourfold by 30 minutes. Fetal glucose concentration fell to approximately 75% of control values. Both arterial and umbilical venous alanine contents fell significantly (p < 0.01), yet the fetal alanine venous-arterial difference also fell significantly (p < 0.05) by 30 minutes. Fetal alanine uptake from the pooled experiments did not change significantly after tolbutamide. When only insulin responses of less than 150 μU/ml were considered, however, a significant (p < 0.02) fall in alanine uptake was noted. Two injections in one animal caused peak insulin levels above 150 μU/ml. Although limited, data from these latter experiments suggested an increase in fetal alanine uptake at these higher insulin concentrations. Thus, endogenous fetal insulin release caused a significant hyperinsulinism and consequent hypoglycemia. The fetal hypoalaninemia produced may have been due to a number of factors, including an acute decrease in placental alanine transfer and decreased fetal hepatic giuconeogenesis. A differential effect of high versus low insulin responses upon fetal alanine uptake is also suggested.

Original languageEnglish (US)
Pages (from-to)22-26
Number of pages5
JournalAmerican Journal of Obstetrics and Gynecology
Volume139
Issue number1
StatePublished - Jan 1 1981
Externally publishedYes

Fingerprint

Alanine
Insulin
Tolbutamide
Umbilicus
Hyperinsulinism
Hypoglycemia
Fetus
Amino Acids
Glucose
Injections
Liver

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Effect of endogenous insulin release on fetal alanine concentration and uptake. / Philipps, Anthony F; Dubin, Joseph W.; Raye, John R.

In: American Journal of Obstetrics and Gynecology, Vol. 139, No. 1, 01.01.1981, p. 22-26.

Research output: Contribution to journalArticle

@article{3da11f93585d488694008fe1833bebe1,
title = "Effect of endogenous insulin release on fetal alanine concentration and uptake",
abstract = "Insulin secretion in the fetus may be important in the modulation of selected fetal amino acid concentration and uptakes. To test this hypothesis we observed the changes in fetal alanine concentrations and uptake after tolbutamide-induced insulin release in the fetal lamb. The basal umbilical venous-arterial alanine difference was 29.1 ± 4.2 μmoles/L. Fetal alanine uptake was 5.1 ± 0.6 μmoles/kg/min. After tolbutamide infusion fetal insulin concentration rose fourfold by 30 minutes. Fetal glucose concentration fell to approximately 75{\%} of control values. Both arterial and umbilical venous alanine contents fell significantly (p < 0.01), yet the fetal alanine venous-arterial difference also fell significantly (p < 0.05) by 30 minutes. Fetal alanine uptake from the pooled experiments did not change significantly after tolbutamide. When only insulin responses of less than 150 μU/ml were considered, however, a significant (p < 0.02) fall in alanine uptake was noted. Two injections in one animal caused peak insulin levels above 150 μU/ml. Although limited, data from these latter experiments suggested an increase in fetal alanine uptake at these higher insulin concentrations. Thus, endogenous fetal insulin release caused a significant hyperinsulinism and consequent hypoglycemia. The fetal hypoalaninemia produced may have been due to a number of factors, including an acute decrease in placental alanine transfer and decreased fetal hepatic giuconeogenesis. A differential effect of high versus low insulin responses upon fetal alanine uptake is also suggested.",
author = "Philipps, {Anthony F} and Dubin, {Joseph W.} and Raye, {John R.}",
year = "1981",
month = "1",
day = "1",
language = "English (US)",
volume = "139",
pages = "22--26",
journal = "American Journal of Obstetrics and Gynecology",
issn = "0002-9378",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Effect of endogenous insulin release on fetal alanine concentration and uptake

AU - Philipps, Anthony F

AU - Dubin, Joseph W.

AU - Raye, John R.

PY - 1981/1/1

Y1 - 1981/1/1

N2 - Insulin secretion in the fetus may be important in the modulation of selected fetal amino acid concentration and uptakes. To test this hypothesis we observed the changes in fetal alanine concentrations and uptake after tolbutamide-induced insulin release in the fetal lamb. The basal umbilical venous-arterial alanine difference was 29.1 ± 4.2 μmoles/L. Fetal alanine uptake was 5.1 ± 0.6 μmoles/kg/min. After tolbutamide infusion fetal insulin concentration rose fourfold by 30 minutes. Fetal glucose concentration fell to approximately 75% of control values. Both arterial and umbilical venous alanine contents fell significantly (p < 0.01), yet the fetal alanine venous-arterial difference also fell significantly (p < 0.05) by 30 minutes. Fetal alanine uptake from the pooled experiments did not change significantly after tolbutamide. When only insulin responses of less than 150 μU/ml were considered, however, a significant (p < 0.02) fall in alanine uptake was noted. Two injections in one animal caused peak insulin levels above 150 μU/ml. Although limited, data from these latter experiments suggested an increase in fetal alanine uptake at these higher insulin concentrations. Thus, endogenous fetal insulin release caused a significant hyperinsulinism and consequent hypoglycemia. The fetal hypoalaninemia produced may have been due to a number of factors, including an acute decrease in placental alanine transfer and decreased fetal hepatic giuconeogenesis. A differential effect of high versus low insulin responses upon fetal alanine uptake is also suggested.

AB - Insulin secretion in the fetus may be important in the modulation of selected fetal amino acid concentration and uptakes. To test this hypothesis we observed the changes in fetal alanine concentrations and uptake after tolbutamide-induced insulin release in the fetal lamb. The basal umbilical venous-arterial alanine difference was 29.1 ± 4.2 μmoles/L. Fetal alanine uptake was 5.1 ± 0.6 μmoles/kg/min. After tolbutamide infusion fetal insulin concentration rose fourfold by 30 minutes. Fetal glucose concentration fell to approximately 75% of control values. Both arterial and umbilical venous alanine contents fell significantly (p < 0.01), yet the fetal alanine venous-arterial difference also fell significantly (p < 0.05) by 30 minutes. Fetal alanine uptake from the pooled experiments did not change significantly after tolbutamide. When only insulin responses of less than 150 μU/ml were considered, however, a significant (p < 0.02) fall in alanine uptake was noted. Two injections in one animal caused peak insulin levels above 150 μU/ml. Although limited, data from these latter experiments suggested an increase in fetal alanine uptake at these higher insulin concentrations. Thus, endogenous fetal insulin release caused a significant hyperinsulinism and consequent hypoglycemia. The fetal hypoalaninemia produced may have been due to a number of factors, including an acute decrease in placental alanine transfer and decreased fetal hepatic giuconeogenesis. A differential effect of high versus low insulin responses upon fetal alanine uptake is also suggested.

UR - http://www.scopus.com/inward/record.url?scp=0019379969&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019379969&partnerID=8YFLogxK

M3 - Article

C2 - 7006399

AN - SCOPUS:0019379969

VL - 139

SP - 22

EP - 26

JO - American Journal of Obstetrics and Gynecology

JF - American Journal of Obstetrics and Gynecology

SN - 0002-9378

IS - 1

ER -